Zix Corp (ZIXI)

Common Stock

8.485  -0.01 (-0.06%)

After market: 8.485 0 (0%)

Fundamental Rating

2

Overall ZIXI gets a fundamental rating of 2 out of 10. We evaluated ZIXI against 277 industry peers in the Software industry. Both the profitability and financial health of ZIXI have multiple concerns. While showing a medium growth rate, ZIXI is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year ZIXI was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -2.38%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -4.38%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ZIXI has more shares outstanding
Compared to 1 year ago, ZIXI has a worse debt to assets ratio.

2.2 Solvency

ZIXI has an Altman-Z score of 0.58. This is a bad value and indicates that ZIXI is not financially healthy and even has some risk of bankruptcy.
ZIXI has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

ZIXI has a Current Ratio of 0.76. This is a bad value and indicates that ZIXI is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.76 indicates that ZIXI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.35% over the past year.
Measured over the past years, ZIXI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.42% on average per year.
The Revenue has grown by 16.39% in the past year. This is quite good.
Measured over the past years, ZIXI shows a very strong growth in Revenue. The Revenue has been growing by 31.91% on average per year.
EPS 1Y (TTM)4.35%
EPS 3Y29.28%
EPS 5Y22.42%
EPS growth Q2Q-11.76%
Revenue 1Y (TTM)16.39%
Revenue growth 3Y49.27%
Revenue growth 5Y31.91%
Revenue growth Q2Q18.25%

3.2 Future

ZIXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.20% yearly.
Based on estimates for the next years, ZIXI will show a quite strong growth in Revenue. The Revenue will grow by 14.54% on average per year.
EPS Next Y-0.53%
EPS Next 2Y6.88%
EPS Next 3Y6.07%
EPS Next 5Y6.2%
Revenue Next Year16.62%
Revenue Next 2Y15.11%
Revenue Next 3Y14.35%
Revenue Next 5Y14.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

ZIXI is valuated correctly with a Price/Earnings ratio of 14.14.
ZIXI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.02.
Based on the Price/Forward Earnings ratio of 12.28, the valuation of ZIXI can be described as correct.
The average S&P500 Price/Forward Earnings ratio is at 20.58. ZIXI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.14
Fwd PE 12.28

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.57

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y6.88%
EPS Next 3Y6.07%

0

5. Dividend

5.1 Amount

ZIXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Zix Corp

NASDAQ:ZIXI (12/22/2021, 7:55:27 PM)

After market: 8.485 0 (0%)

8.485

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap468.20M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.14
Fwd PE 12.28
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA -2.38%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -0.24%
PM (TTM) -4.38%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)4.35%
EPS 3Y29.28%
EPS 5Y
EPS growth Q2Q
EPS Next Y-0.53%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.39%
Revenue growth 3Y49.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y